Alters Braf/MEK/ERK1/2 and Akt signaling pathways by inhibiting HMGCR, which can inhibit cell growth, induce apoptosis, and inhibit tumorigenesis in non-small cell lung cancer (Zhang et al., 2019). The gene discussed is HMGCR; the disease is non-small cell lung carcinoma.